Form 4: Precision BioSciences Director Kevin Buehler Acquires Additional Shares

Director Kevin Buehler of Precision BioSciences, Inc. (DTIL) purchased 4,523 shares of common stock at an average price of $4.67 on March 26, 2025.

Summary

• On March 26, 2025, Kevin Buehler, a director of Precision BioSciences, Inc. (DTIL), acquired 4,523 shares of common stock.
• The shares were purchased at a weighted average price of $4.67, with individual transaction prices ranging from $4.62 to $4.67.
• Following the transaction, Buehler directly owns 13,235 shares of Precision BioSciences common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide investors with insights into the actions of company insiders, such as directors and officers, regarding their holdings of the company's securities.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Precision BioSciences, DTIL, Kevin Buehler, stock purchase, director, Form 4, beneficial ownership, common stock